Spark Biomedical Receives Health Canada’s Medical Device License for Sparrow Ascent Opioid Withdrawal Treatment

New Health Canada Approval Allows Spark Biomedical to Offer Drug-Free Opioid Withdrawal Relief Across Canada.

Dallas, TX – [Mar 2025] – Spark Biomedical, a leader in wearable neurostimulation technology, announces the receipt of its Medical Device License from Health Canada for Sparrow AscentTM, an FDA-cleared non-invasive, drug-free, neurostimulation device for opioid withdrawal. The approval of this license allows Spark Biomedical to bring its innovative solution to individuals and healthcare providers across Canada, offering a safe, comfortable, drug –free withdrawal treatment option for those with opioid use disorder. Safe Science Solutions will serve as the exclusive distribution partner for Sparrow Ascent in Canada.

“Receiving Health Canada’s Medical Device License is a significant milestone in our mission to provide a safe, drug-free solution for opioid withdrawal.” says Dan Powell, CEO of Spark Biomedical. “This approval means we can now bring Sparrow Ascent to the people of Canada—offering hope, relief, and a real path forward for those battling opioid dependence. Through our partnership with Safe Science Solutions, we’re committed to making this groundbreaking treatment accessible to those who need it most.”

‍